Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

Update Il y a 4 ans
Reference: NCT00290355

Woman and Man

Extract

Patients will receive injections of GSK 249553 vaccine . Appropriate tests will be performed to assess the safety of the treatment and its ability to induce an immune response.


Inclusion criteria

  • Lung Cancer, Non-Small Cell


Links